Questionnaire Survey of Female Patients with Atopic Dermatitis Regarding Genital Skin Condition

2010 ◽  
Vol 72 (4) ◽  
pp. 385-389
Author(s):  
Miwa KOBAYASHI ◽  
Yoshiki TOKURA ◽  
Noriko SATO ◽  
Yutaka TAKAGI ◽  
Takashi KITAHARA ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Questionnaire Survey ◽  
Skin Condition ◽  
Female Patients

scholarly journals Electrospun PCL Patches with Controlled Fiber Morphology and Mechanical Performance for Skin Moisturization via Long-Term Release of Hemp Oil for Atopic Dermatitis

Membranes ◽  
2020 ◽  
Vol 11 (1) ◽  
pp. 26
Author(s):  
Sara Metwally ◽  
Daniel P. Ura ◽  
Zuzanna J. Krysiak ◽  
Łukasz Kaniuk ◽  
Piotr K. Szewczyk ◽  
...  
Keyword(s):  
Mechanical Properties ◽  
Atopic Dermatitis ◽  
Mechanical Performance ◽  
Antibacterial Properties ◽  
Skin Condition ◽  
Fiber Morphology ◽  
Suitable Material ◽  
Hemp Oil ◽  
Skin Moisture

Atopic dermatitis (AD) is a chronic, inflammatory skin condition, caused by wide genetic, environmental, or immunologic factors. AD is very common in children but can occur at any age. The lack of long-term treatments forces the development of new strategies for skin regeneration. Polycaprolactone (PCL) is a well-developed, tissue-compatible biomaterial showing also good mechanical properties. In our study, we designed the electrospun PCL patches with controlled architecture and topography for long-term release in time. Hemp oil shows anti-inflammatory and antibacterial properties, increasing also the skin moisture without clogging the pores. It can be used as an alternative cure for patients that do not respond to traditional treatments. In the study, we tested the mechanical properties of PCL fibers, and the hemp oil spreading together with the release in time measured on skin model and human skin. The PCL membranes are suitable material as patches or bandages, characterized by good mechanical properties and high permeability. Importantly, PCL patches showed release of hemp oil up to 55% within 6 h, increasing also the skin moisture up to 25%. Our results confirmed that electrospun PCL patches are great material as oil carriers indicating a high potential to be used as skin patches for AD skin treatment.

Differential Diagnosis of Seborrheic Dermatitis

1986 ◽  
Vol 7 (7) ◽  
pp. 204-211
Author(s):  
Mary L. Williams
Keyword(s):  
Atopic Dermatitis ◽  
Differential Diagnosis ◽  
Metabolic Diseases ◽  
Fungal Infections ◽  
Seborrheic Dermatitis ◽  
Local Therapy ◽  
Skin Condition ◽  
Unknown Etiology ◽  
Common Skin ◽  
Nutritional And Metabolic Diseases

Seborrheic dermatitis is a common skin condition of infancy of unknown etiology. The disorder is usually mild and responsive to therapy. In severe or atypical cases, a variety of other entities should be considered in the differential diagnosis. Atopic dermatitis, psoriasis, psoriasiform-id reaction, fungal infections, and irritant contact dermatitis can be differentiated on clinical grounds. Less common but more serious disorders, such as histiocytosis X, immunodeficiency disorders, and nutritional and metabolic diseases, may be considered in the child whose disease does not spontaneously resolve or respond satisfactorily to local therapy. Laboratory studies including skin biopsy may be helfpul in these cases. Seborrheic dermatitis is uncommon in children after infancy and before puberty. In this age group, scalp scaling is likely to be due to other causes, such as tinea capitis, atopic dermatitis, or psoriasis.

scholarly journals Surveillance of home environment in children with atopic dermatitis: a questionnaire survey

2012 ◽  
Vol 2 (1) ◽  
pp. 59 ◽  
Author(s):  
Jung Hyun Lee ◽  
Jungmin Suh ◽  
Eun Hye Kim ◽  
Joong Bum Cho ◽  
Hwa Young Park ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Home Environment ◽  
Questionnaire Survey

Clinical Insights About Topical Treatment of Mild-to-Moderate Pediatric and Adult Atopic Dermatitis

2019 ◽  
Vol 23 (3_suppl) ◽  
pp. 3S-13S ◽  
Author(s):  
Charles W. Lynde ◽  
James Bergman ◽  
Loretta Fiorillo ◽  
Lyn Guenther ◽  
Jill Keddy-Grant ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Calcineurin Inhibitors ◽  
Skin Condition ◽  
Future Research ◽  
Barrier Dysfunction ◽  
Psychosocial Burden ◽  
Epidermal Barrier ◽  
Topical Corticosteroids ◽  
Topical Calcineurin Inhibitors ◽  
Inflammatory Conditions

Atopic dermatitis (AD) is a chronic inflammatory skin condition, also referred to as atopic eczema, that is identified by itching and recurrent eczematous lesions. It often starts in infancy where it affects up to 20% of children but is also highly prevalent in adults. AD inflicts a significant psychosocial burden on patients and their families and increases the risk of other immune-mediated inflammatory conditions, such as asthma and allergic rhinitis, food allergy, and mental health disorders. It is a lifelong condition associated with epidermal barrier dysfunction and altered immune function. Through the use of emollients and anti-inflammatory agents, current prevention and treatment therapies attempt to restore epidermal barrier function. Acute flares are treated with topical corticosteroids. Topical calcineurin inhibitors (TCIs) and topical corticosteroids (TCSs) are used for proactive treatment to prevent remission. There remains a need and opportunity to improve AD care through future research directed toward an improved understanding of the heterogeneity of the disease and its subtypes, the role of autoimmunity in its pathogenesis, the mechanisms behind disease-associated itch and response to specific allergens, and the comparative effectiveness and safety of therapies.

scholarly journals Sleep problems in 0-36 months old Indonesian children with atopic dermatitis

2019 ◽  
Author(s):  
I. Irwanto ◽  
Hapsari W. Ningtiar ◽  
Taufiq Hidayat ◽  
Azwin M. Putera ◽  
Zahrah Hikmah ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Sleep Problems ◽  
Sleep Onset ◽  
Onset Time ◽  
Skin Condition ◽  
Chi Square ◽  
Falling Asleep ◽  
Chi Square Test ◽  
And Behavior ◽  
And Control

Atopic dermatitis (AD) is a chronic, relapsing, highly pruritic skin condition that develops in early childhood. Sleep problems are common in AD children and lead to impaired quality of life, disturbance of neurocognitive function and behavior. The aim of this study was to assess the prevalence of sleep problems in 0-36 months old Indonesian children with AD. Children aged 0-36 months were enrolled, divided into two groups, AD and control. Sleep problems and AD were assessed using Brief Infant Sleep Questionnaire (BISQ) and Severity Scoring of Atopic Dermatitis Index (SCORAD). Chi-square test was performed to compare the outcome. There were 35 children participating in each group. In children with sleep problems, 85.7% were diagnosed with AD and 11.4% were non-AD. Nocturnal sleep duration, night waking, nocturnal wakefulness, sleep onset time, method of falling asleep and parental consideration of sleep problems occur more often within AD group. Severity of AD also significantly contributes to sleep problems in AD group. In conclusion, this study showed that sleep problems are more prevalent in children with AD.

Premenstrual Deterioration of Skin Symptoms in Female Patients with Atopic Dermatitis

Dermatology ◽  
2003 ◽  
Vol 206 (2) ◽  
pp. 110-112 ◽  
Author(s):  
Keiko Kiriyama ◽  
Hisashi Sugiura ◽  
Masami Uehara
Keyword(s):  
Atopic Dermatitis ◽  
Female Patients ◽  
Skin Symptoms
Sign in / Sign up

Export Citation Format

Share Document